NCT02671682View on ClinicalTrials.gov

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

February 26, 2016

Primary Completion Date

January 3, 2019

Study Completion Date

January 25, 2019

Conditions
Multiple SclerosisClinically Isolated Syndrome
Interventions
PROCEDURE

Immunoadsorption

PROCEDURE

Plasmapheresis

Trial Locations (1)

89081

Department of Neurology, University of Ulm, Ulm

All Listed Sponsors
lead

Albert Christian Ludolph, Prof.

OTHER

NCT02671682 - Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis | Biotech Hunter | Biotech Hunter